Successful HLA-identical unrelated allogeneic bone marrow transplantation with a very low dose of stem cells for a patient with chronic myeloid leukemia in blast crisis

被引：0

作者：

Arai, H ^{[1
]}

Arai, Y ^{[1
]}

Haraguchi, K ^{[1
]}

Nakamura, Y ^{[1
]}

Tsurumi, S ^{[1
]}

Maki, K ^{[1
]}

Aoyagi, A ^{[1
]}

Nakamura, Y ^{[1
]}

Saito, K ^{[1
]}

Mitani, K ^{[1
]}

机构：

[1] Dokkyo Univ, Sch Med, Dept Hematol, Shimotsuga, Tochigi 3210293, Japan

来源：

LEUKEMIA & LYMPHOMA | 2002年 / 43卷 / 10期

关键词：

allogeneic bone marrow transplantation; chronic myelocytic leukemia; engraftment; stem cells; low dose; molecular remission;

D O I：

10.1080/10428190213671

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：2067 / 2069

页数：3

共 9 条

[1] EFFECT OF HLA COMPATIBILITY ON ENGRAFTMENT OF BONE-MARROW TRANSPLANTS IN PATIENTS WITH LEUKEMIA OR LYMPHOMA [J].

ANASETTI, C ;

AMOS, D ;

BEATTY, PG ;

APPELBAUM, FR ;

BENSINGER, W ;

BUCKNER, CD ;

CLIFT, R ;

DONEY, K ;

MARTIN, PJ ;

MICKELSON, E ;

NISPEROS, B ;

OQUIGLEY, J ;

RAMBERG, R ;

SANDERS, JE ;

STEWART, P ;

STORB, R ;

SULLIVAN, KM ;

WITHERSPOON, RP ;

THOMAS, ED ;

HANSEN, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (04) :197-204

[2]

BACIGALUPO A, 1995, BONE MARROW TRANSPL, V15, P221

[3] The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia [J].

Byrne, JL ;

Stainer, C ;

Cull, G ;

Haynes, AP ;

Bessell, EM ;

Hale, G ;

Waldmann, H ;

Russell, NH .

BONE MARROW TRANSPLANTATION, 2000, 25 (04) :411-417

[4]

Champlin R E, 1990, Cancer Treat Res, V50, P99

[5]

DAVIES SM, 1994, BONE MARROW TRANSPL, V14, P73

[6] Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation [J].

Grandage, VL ;

Cornish, JM ;

Pamphilon, DH ;

Potter, MN ;

Steward, CG ;

Oakhill, A ;

Marks, DI .

BONE MARROW TRANSPLANTATION, 1998, 21 (07) :687-690

[7]

NEMUNAITIS J, 1990, BLOOD, V76, P245

[8] Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome [J].

Russell, JA ;

Larratt, L ;

Brown, C ;

Turner, AR ;

Chaudhry, A ;

Booth, K ;

Woodman, RC ;

Wolff, J ;

Valentine, K ;

Stewart, D ;

Ruether, JD ;

Ruether, BA ;

Klassen, J ;

Jones, AR ;

Gyonyor, E ;

Egeler, M ;

Dunsmore, J ;

Desai, S ;

Coppes, MJ ;

Bowen, T ;

Anderson, R ;

Poon, MC .

BONE MARROW TRANSPLANTATION, 1999, 24 (11) :1177-1183

[9] HEMATOPOIETIC GROWTH-FACTORS FOR GRAFT FAILURE AFTER BONE-MARROW TRANSPLANTATION - A RANDOMIZED TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) VERSUS SEQUENTIAL GM-CSF PLUS GRANULOCYTE-CSF [J].

WEISDORF, DJ ;

VERFAILLIE, CM ;

DAVIES, SM ;

FILIPOVICH, AH ;

WAGNER, JE ;

MILLER, JS ;

BURROUGHS, J ;

RAMSAY, NKC ;

KERSEY, JH ;

MCGLAVE, PB ;

BLAZAR, BR .

BLOOD, 1995, 85 (12) :3452-3456

← 1 →